Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland

Sexually Transmitted Infections

Volumn 82, Issue 2, 2006, Pages 159-163

  Smith, J S ^b   Rosinska M ^a   Trzcinska A ^a   Pimenta, J M ^c   Litwinska B ^a   Siennicka, Joanna ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLAND; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; POLAND; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 33645823209     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.015446     Document Type: Review

References (37)

1. Whitley R, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998;26:541-55.
2. Roizman B, Sears AE. Herpes simplex viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott-Raven, 1996.
3. Aurelian L. Herpes simplex viruses (Herpesviridae). General features. In, Granoff A, Webster RG, eds. Encyclopedia of virology London, Academic Press, 1999.
4. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type- specific serology. Clin Microbiol Rev 1999;12:1-8.
5. Kinghom GR. Herpes simplex type 1 genital infections. Herpes 1999;6:4-7.
6. Brugha R, Keersmaekers K, Renton A, et al. Genital herpes infection: a review. Int J Epidemiol 1997;26:698-709.
7. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
8. Wald A, Corey L, Cone R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997;99:1092-7.
9. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infection. N Engl J Med 1995;333:770-5.
10. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus type 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1):S3-S8.
11. Stanberry L. The epidemiology of herpes simplex virus infections in adolescents. Herpes 1999;6:12-5.
12. Central Statistical Office. Statistical yearbook of the regions-Poland, 2003 (data for 2002). Warsaw, 2003.
13. Strick L, Wald A. Type-specific testing for herpes simplex virus. Expert Rev Mol Diagn 2004;4:443-53.
14. Ashley-Morrow R, Nollkamper J, Robinson NJ, et al. Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004;10:530-6.
15. De Sanjosé S, Muñoz N, Bosch FX, et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994;56:358-63.
16. Morris-Cunnington M, Brown D, Pimenta J, et al. New estimates of herpes simplex virus type 2 seroprevalence in England: 'high' but stable seroprevalence over the last decade. Sex Transm Dis 2004;31:243-6.
17. De Ory F, Pachon I, Echevarria JM, et al. Seroepidemiological study of herpes simplex virus in the female population in the autonomous region of Madrid, Spain. Eur J Clin Microbiol Infect Dis 1999;18:678-80.
18. Garcia-Corbeira P, Dal Re R, Aguilar L, et al. Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population? J Med Virol 1999;59:194-7.
19. Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004;80:185-91.
20. Pasquini P, Mele A, Franco E, et al. Prevalence of herpes simplex virus type 2 antibodies in selected population groups in Italy. Eur J Clin Microbiol Infect Dis 1988;7:54-6.
21. Eskild A, Jeansson S, Jenum PA. Herpes simplex-virus type 2-antistoffer has gravide i Norge. Tidsskr Nor Loegeforen 1999;119:2323-6.
22. Olsen AO, Orstavik I, Dillner J, et al. Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III. APMIS 1998;106:417-24.
23. Persson K, Mansson A, Jonsson E, et al. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995;27:195-9.
24. Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-16.
25. Imbs D, Rudnicka H. Seroepidemiological investigations for cytomegalovirus (CMV) and herpes simplex virus (HSV) infections in girls and women. Przeg Epid 1987;41:286-94.
26. Laskus T, Radkowski G, Halama R, et al. Cytomegalovirus and herpes simplex virus infection in alcoholics and drug addicts. Przeg Epid 1991;45:263-6.
27. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
28. Eberhart-Phillips J, Dickson NP, Paul C, et al. Herpes simplex type 2 infection in a cohort aged 21 years. Sex Transm Infect 1998;74:216-18.
29. Laubereau B, Zwahlen M, Neuenschwander B, et al. Herpes simplex virus type 1 and 2 in Switzerland. Schweiz Med Wochenschr 2000;130:143-50.
30. Dobbins JG, Mastro TD, Nopkesorn T, et al. Herpes in the time of AIDS: a comparison of the epidemiology of HIV-1 and HSV-2 in young men in northern Thailand. Sex Transm Dis 1999;26:67-74.
31. Celum CL. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 2004;11(Suppl 1):36A-45A.
32. Wutzler P, Doerr HW, Farber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 2000;61:201-7.
33. Franco E, Caprilli F, Zaratti L, et al. Prevalence of antibodies to herpes simplex virus type 1 in different population groups in Italy [letter]. Eur J Clin Microbiol 1987;6:322.
34. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002;347:1652-01.
35. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341:1432-8.
36. Arvaja M, Lehtinen M, Koskela P, et al. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect 1999;75:168-71.
37. Vyse AJ, Gay NJ, Slomka MJ, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76:183-7.